目的：探讨血清硫酸粘多糖片段的检测对非小细胞性肺癌诊断的临床应用价值，为肺癌的早期诊断提供依据。
Objective: To explore the clinical value of the detection of the serum sulfate glycosaminoglycan in the diagnosis of no small cell lung caner (NSCLC).
目的研究蛋白激酶C（PKC）、粘附分子CD44变构体CD44V3-10在非小细胞性肺癌（NSCLC）中定量表达及在肺癌发生及转移中的作用。
To investigate the quantitative expression and roles of protein kinase C (PKC), Variant CD44 (CD44V3-10) adhesion molecules in Non-small cellular lung cancer (NSCLC).
目的探讨系统性纵隔淋巴结清扫在非小细胞肺癌外科治疗上的临床意义。
Objective To investigate the clinical significance of systematic mediastinal lymphadenectomy in surgical treatment of non-small cell lung carcinoma.
目的：评价国产药与进口药盐酸吉西他滨治疗非小细胞肺癌(NSCLC)的疗效、安全性及不良反应。
Objective: To evaluate the curative effect, safety and adverse reaction of domestic and imported gemcitabine hydrochloride in non-small cell lung cancer (NSCLC).
目的：探讨血清tps(组织多肽特异性抗原)水平与非小细胞肺癌(NSCLC)患者生物学特征的相关性及其临床应用价值。
Objective: To investigate the levels and clinical value of tissue polypeptide specific antigen (TPS) in serum of patients with non-small cell lung cancer (NSCLC).
目的观察国产紫杉醇联合顺铂治疗50例晚期非小细胞肺癌的临床疗效和安全性。
Objective To observe clinical chemotherapeutic efficacy and safety of paclitaxel plus cisplatin in the treatment of 50 cases with advanced non-small cell lung cancer.
结论：NP方案序贯放疗治疗局部晚期非小细胞肺癌疗效明显，耐受性好。
Conclusion: the NP regimen plus sequential radiotherapy is rather active for locally advanced non-small-cell lung cancer with acceptable tolerance.
目的：观察榄香烯乳剂联合化疗治疗晚期非小细胞肺癌的疗效与安全性。
Conclusion: Elemene emulsion combined with chemotherapy may make the life quality become better and increase the treatment effects of patients with advanced non-small cell lung cancer.
目的探讨晚期非小细胞肺癌（NSCLC）患者凝血指标分布特点及与患者预后、中医证型和远期血栓性事件的相关性。
The incidence of adverse thrombotic events was higher in the advanced NSCLC group than in the non-advanced NSCLC group.
目的探索治疗非小细胞肺癌伴癌性胸膜炎的新方法以提高生存期及生存质量。
Objective to lengthen the survival time and improve the QOL of the patients of Non-small Cell Lung Cancer (NSCLC) with carcinomatous pleuritis by the new surgical treatment strategy we have developed.
在经过选择的晚期非小细胞肺癌患者，减状性手术应为综合治疗的一部分。
Palliative surgery should be a part of multidisciplinary therapy for selective patients with advanced NSCLC.
井上说：“这是一个理想的个体化治疗转移性非小细胞肺癌的开始。”
"This is a beginning of the ideal individualized treatment for metastatic non-small-cell lung cancer," said Inoue.
目的回顾性分析372例晚期非小细胞肺癌患者的生存现状，评估各类因素对生存期的影响。
Objective Retrospective analysis was conducted on the survival situation of 372 patients with advanced NSCLC, to assess the effects of various factors on survival time.
目的评价国产多西紫杉醇治疗晚期非小细胞肺癌的临床疗效和安全性。
Objective To investigate the efficacy and safety of domestic docetaxel plus cisplatin regimen in patients with advanced non-small-cell lung cancer (NSCLC).
目的：探讨CT引导下经皮穿刺种植植入用缓释顺铂粒子联合放射性125I粒子治疗晚期非小细胞肺癌（NSCLC）的短期疗效。
Objective: To evaluate the effect of combined Cisplatin Sustained Release for Implant with radioactive iodine-125(125I) to non-small cell lung cancer(NSCLC) guided by CT.
目的对75岁以上无远处转移非小细胞肺癌患者单纯放疗和联合放、化疗的疗效进行回顾性分析。
Objective To evaluate the effect between radiotherapy alone and combined radio chemotherapy on more than 75 year old patients with m 0 NSCLC by retrospective analysis.
这是一例转移性非小细胞肺癌。
结论：NSCLC组织SUV值与组织EGFR表达有显著相关性，可以为非小细胞肺癌的放疗提供指导。
Conclusions: The SUVmax is correlated positively with EGFR expression in NSCLC, which can provide the guidance for radiotherapy.
结论：对非小细胞肺癌患者进行化疗药物敏感实验具有可行性和必要性，对于临床个体化化疗具有现实指导作用。
Conclusions: Chemotherapeutic drug sensitivity test was feasible and necessary for the patients of NSCLC and has its practical guidance for clinical individual chemotherapy.
目的观察吉非替尼单药治疗对晚期非小细胞肺癌 （NSCLC）老年患者的效果和安全性。
Objective To evaluate the efficacy and safety of gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
目的：研究中国北方人非小细胞肺癌(NSCLC)的易感性和放疗敏感性与TP53基因多态性的关系。
Objective To study the association of polymorphism in TP53 gene with the susceptibility and radiation sensitivity of non-small-cell-lung cancer (NSCLC) of the population in the North of China.
方法回顾性研究肿瘤科2006年- 2009年间12例非小细胞肺癌脑转移患者。
Methods This was a retrospective study. From 2006 to 2009, There were 12 cases of NSCLC with brain metastases.
结论厄洛替尼单药对晚期非小细胞肺癌合并COPD的患者不良反应小，耐受性好，疗效可接受。
Conclusion For elderly patients with advanced non-small cell lung cancer and COPD, the use of erlotinib might achieve better security and effectiveness.
评价单药厄洛替尼治疗晚期非小细胞肺癌合并COPD患者的疗效和安全性。
To evaluate the clinical efficacy and the security of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer and COPD.
评价单药厄洛替尼治疗晚期非小细胞肺癌合并COPD患者的疗效和安全性。
To evaluate the clinical efficacy and the security of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer and COPD.
应用推荐